These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1300783)

  • 1. [The assessment of cellular immunity parameters in patients with breast cancer and lymphogranulomatosis during dynamic treatment].
    Baldueva IA; Pukhova ZhK; Gavrilenkova LP; Mosberger ID
    Vopr Onkol; 1992; 38(7):787-92. PubMed ID: 1300783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hodgkin's disease--immunological aspects].
    Plat M; Frank KH; Fleischer J; Plat U; Koslowski R
    Allerg Immunol (Leipz); 1988; 34(3):139-58. PubMed ID: 3057835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic monitoring in carcinoma of the breast.
    Weese JL; Oldham RK; Tormey DC; Barlock AL; Morales A; Cohen MH; West WH; Herberman RB; Alford TC; Shorb PE; Tsangaris NT; Cannon GB; Dean JH; Djeu J; McCoy JL
    Surg Gynecol Obstet; 1977 Aug; 145(2):209-18. PubMed ID: 141745
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of host immune response in breast cancer patients.
    Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
    Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer.
    Olusi SO; Oluwole SF; Odesanmi WO
    Afr J Med Med Sci; 1984; 13(3-4):103-9. PubMed ID: 6099969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T-lymphocyte subsets of peripheral blood monocytes and their ability to form T-cell colony in breast tumor].
    Zhang LH
    Zhonghua Wai Ke Za Zhi; 1991 Sep; 29(9):558-60, 589. PubMed ID: 1813259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of T lymphocyte defects in patients with Hodgkin's disease using enzyme chemical markers].
    Wendt C; Schön E; Gaede B; Franke A; Ansorge S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):851-7. PubMed ID: 1713892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The lymphocyte immunological phenotype of young and middle-aged breast cancer patients].
    Chobanian NS; Letiagin VP; Savel'eva EV; Zabotina TN; Baryshnikov AIu; Kadagidze ZG
    Vopr Onkol; 1992; 38(5):548-54. PubMed ID: 1300753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal natural killer cell activity in Hodgkin's disease patients in remission.
    Douer D; Shaked N; Ramot B
    Clin Exp Immunol; 1987 Sep; 69(3):660-7. PubMed ID: 3665188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology and cellular biology of Hodgkin's disease.
    Slivnick DJ; Nawrocki JF; Fisher RI
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):205-20. PubMed ID: 2663823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune homeostasis in patients with head and neck cancer].
    Savina NP; Medvedev VS
    Vopr Onkol; 1991; 37(6):671-6. PubMed ID: 1843143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoregulatory subpopulations of T-lymphocytes and their distribution in the peripheral blood, lymph nodes and spleen of patients with lymphogranulomatosis].
    Kharabadze MV; Tabagari DZ
    Ter Arkh; 1989; 61(7):30-2. PubMed ID: 2686065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differentiation of lymphocyte populations in the blood of breast-cancer patients].
    Weber W; Nagel GA; Obrist R; Nagel E; Heitz P; Oberholzer M; Herzig D
    Schweiz Med Wochenschr; 1977 Jul; 107(28):1010-2. PubMed ID: 331468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
    Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various immunomorphological tests of cellular immunity in lymphogranulomatosis].
    Gelenko AM
    Arkh Patol; 1979; 41(1):18-21. PubMed ID: 106807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.